An interventional study of Tablet-based training and ergotherapeutic training in Stroke and Hemiparesis, sponsored by BDH-Klinik Hessisch Oldendorf. Completed at 1 site in Germany. Open to participants aged 36 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-20.
Sponsored by BDH-Klinik Hessisch Oldendorf · Not applicable, Interventional, and Basic science
Among 356 studies in Stroke with a site in Germany — 51 open to participants now, 66 under way, 8 of them phase 3. Stroke · Germany.
Among the 356 studies in Stroke with a site in Germany, this one is the 170th largest by enrollment of the 222 interventional ones that give a count, is one of 10 that started in 2022, is one of 104 with no phase, and was the 305th registered.
8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.
This study's enrollment of 40 is below the median of 49 across 6,024 interventional studies indexed under Stroke.
Browse Stroke studies →51 of the 356 studies in Stroke with a site in Germany are open now, in 12 countries. Each count lists the studies.
Of the 1,415 Stroke studies recruiting now, 697 (49%) set no upper age limit and 280 (20%) stop at 75 or younger; 77 take children under 18; 196 take healthy volunteers.
This study: 36 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →356 studies; the count open now beside each. This study's row is marked.
First in 1994; this study’s year is marked. 10 started in 2022.
Median enrollment 200 across the 222 interventional studies, 368 across the 133 observational. Of the 242 that completed or were terminated, 52 (21%) have results posted.
125 of 356 have an industry lead sponsor. The 10 most frequent:
BDH-Klinik Hessisch Oldendorf is the lead sponsor of 13 studies on the registry; 5 are open to participants now.
BDH-Klinik Hessisch Oldendorf has 4 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
17 of the studies in Stroke with a site in Germany that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05691244Phase 3Pharmazz, Inc.Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | 2027-09 |
| NCT07357285iVascular S.L.U.Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO) | 2026-11 |
| NCT07885189University Hospital TuebingenLong-Term Cognitive Recovery After Arteria Cerebri Media Ischemia: A Digital Assessment Using the TuCAN-App | 2026-11 |
| NCT06121336Ludwig-Maximilians - University of MunichPRecisiOn Medicine In StrokE: Evolution of Plasma Brain-Derived Tau in Acute Stroke | 2026-12-31 |
| NCT07299994Sigmund Freud PrivatUniversitatEfficacy and Safety of Intravenous Thrombolysis in Branch Atheromatous Disease | 2026-12-31 |
Among the 356 studies in Stroke with a site in Germany, from their registry updates:
Hemiparesis is a frequently observed symptom of stroke. There are various therapy options that are used in the rehabilitation of patients. Some studies have shown that, in addition to unilateral arm training, bilateral arm training can also lead to positive results in treatment and is a useful addition to therapy. The newly developed app requires the coordination of both arms in certain time sequences and intensities or rhythms and addresses different sensory modalities (visual, auditory and kinesthetic). The aim of the study is to examine whether tablet-based training improves bimanual coordination.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The intervention group trained bimanual coordination once a day for about 31 minutes on a total of ten days using a tablet game. A ball is to be moved on a circular line.
Other: Tablet-based training
The patients in the control group receive an ergotherapeutic therapy unit once a day for the same length of time (approx. 31 minutes) for a total of ten days, in which they train unilaterally. In this therapy unit, the control group uses the "Aximo". This is a comb stand and so-called "rolls" with which plugging tasks can be practiced. The patients should push the rolls into the stand fields with the affected hand. With the plug-in game, the patients can complete different tasks that challenge and train their hand-eye coordination, their fine motor skills and their ability to grasp things (e.g. following a specific pattern based on a template or putting colors in a specific order).
Other: ergotherapeutic training
Each task is performed for one minute, followed by a 2-minute break. After the task has been performed three times, there is a 5-minute break. The training block is then carried out twice more. This means that three "blocks" are carried out for each therapy unit.
A task is performed for one minute at a time, followed by a 2-minute break. Once three rounds have been completed, there is a 5-minute break. As in the intervention group, there are a total of three training blocks.
Change of the hand/arm motor skills (unilateral)
measured by the difference in moving wooden cubes in the Box-and-Block Test (BBT) The BBT measures unilateral gross manual dexterity. The patient has to move as many individual cubes as possible from one side of the box over a partition to the other within one minute. The test takes place in a seated position and is performed sequentially with the non-impaired hand and the affected hand. The number of cubes transported for each side is evaluated.
Time frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
Changes in bimanual coordination 1
measured by the difference in moving wooden cubes in the modified Box-and-Block Test (mBBT) For this, a modified box with three compartments and two partitions is used. The task is to take a cube in one hand, pass it to the other hand over the first partition and then transport it over the second partition to the outer compartment. The dice are then counted in the outer compartment. The dice that fall from one hand to the other in the middle compartment are counted separately. The task is performed twice, starting with the unimpaired hand in the first run and with the impaired hand in the second run. The subject has one minute per round to transport as many cubes as possible to the outer compartment.
Time frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
Changes in bimanual coordination 2
measured by the difference in activity index (calculated from acceleration, movement amplitude and movement frequency during the use of the tablet game)
Time frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
Change of functional abilities
measured by the difference of National Institutes of Health Stroke Scale (NIHSS)
Time frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
Change of activities of daily living
measured by the difference of Barthel-Index (BI)
Time frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
Change of hand strength
Hand strength is measured with a KERN MAP digital hand force gauge. The change of strength (in kg) is calculated.
Time frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
Change of selective motor control after a stroke
measured by the difference of the values of the "Fugl-Meyer-Test" (FMT)
Time frame: Pre-test (day 1), Post-test (day 18), Follow-Up (day 25)
Change of functional connectivity of the motor system
measured by differences between resting state functional magnetic resonance imaging (fMRI) scans
Time frame: Pre-test (day 1), Post-test (day 18)
Plan to share: No
Ran from Oct 2022 to primary completion in Aug 2024, 22 months.
Of 3,108 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's 22 months is close to that.
Counting every sponsor, half of 3,252 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
BDH-Klinik Hessisch Oldendorf